| Revision as of 05:24, 14 April 2022 editFfffrr (talk | contribs)Extended confirmed users99,459 edits Importing Wikidata short description: "Chemical compound" (Shortdesc helper)← Previous edit | Revision as of 14:58, 8 June 2023 edit undoCitation bot (talk | contribs)Bots5,431,926 edits Add: chapter-url, pmid. Removed or converted URL. | Use this bot. Report bugs. | Suggested by Spinixster | Category:Isopropyl compounds | #UCB_Category 11/169Next edit → | ||
| Line 52: | Line 52: | ||
| }} | }} | ||
| '''Isoaminile''' is an ] (cough suppressant) used under the trade-name '''Peracon'''.<ref>{{cite book | vauthors = Chappel CI, von Seeman C | veditors = Ellis GP, West GB | chapter = Antitussive Drugs | title = Progress in Medicinal Chemistry | year = 1963 | volume = 3 | publisher = Butterworth | isbn = 978-0-444-53322-7 | pages = 114–115 | doi = 10.1016/S0079-6468(08)70117-6 | url = https://books.google.com/books?id=PcyoOmjvGzkC&pg=PA114 | access-date = 2013-09-12 }}</ref> | '''Isoaminile''' is an ] (cough suppressant) used under the trade-name '''Peracon'''.<ref>{{cite book | vauthors = Chappel CI, von Seeman C | veditors = Ellis GP, West GB | chapter = Antitussive Drugs | title = Progress in Medicinal Chemistry | year = 1963 | volume = 3 | publisher = Butterworth | isbn = 978-0-444-53322-7 | pages = 114–115 | doi = 10.1016/S0079-6468(08)70117-6 | pmid = 14146305 | chapter-url = https://books.google.com/books?id=PcyoOmjvGzkC&pg=PA114 | access-date = 2013-09-12 }}</ref> | ||
| The normal therapeutic dose is 40–80 mg of the cyclamate salt, with a maximum of five doses in a 24-hour period.{{citation needed|date=January 2013}} In addition to its central antitussive effects, it is also an ], exhibiting both ] and ] actions.{{citation needed|date=January 2013}} | The normal therapeutic dose is 40–80 mg of the cyclamate salt, with a maximum of five doses in a 24-hour period.{{citation needed|date=January 2013}} In addition to its central antitussive effects, it is also an ], exhibiting both ] and ] actions.{{citation needed|date=January 2013}} | ||
Revision as of 14:58, 8 June 2023
Chemical compound | This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Isoaminile" – news · newspapers · books · scholar · JSTOR (November 2011) (Learn how and when to remove this message) |
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.940  |
| Chemical and physical data | |
| Formula | C16H24N2 |
| Molar mass | 244.382 g·mol |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (what is this?) (verify) | |
Isoaminile is an antitussive (cough suppressant) used under the trade-name Peracon.
The normal therapeutic dose is 40–80 mg of the cyclamate salt, with a maximum of five doses in a 24-hour period. In addition to its central antitussive effects, it is also an anticholinergic, exhibiting both antimuscarinic and antinicotinic actions.
References
- Chappel CI, von Seeman C (1963). "Antitussive Drugs". In Ellis GP, West GB (eds.). Progress in Medicinal Chemistry. Vol. 3. Butterworth. pp. 114–115. doi:10.1016/S0079-6468(08)70117-6. ISBN 978-0-444-53322-7. PMID 14146305. Retrieved 2013-09-12.
 | This drug article relating to the respiratory system is a stub. You can help Misplaced Pages by expanding it. |